Stefan Hippenstiel

Humboldt-Universität zu Berlin — Germany

Immunology and Microbiology · Life Sciences

64h-index15.6kcitations328works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(49), Pneumonia and Respiratory Infections(45), COVID-19 Clinical Research Studies(39), SARS-CoV-2 and COVID-19 Research(32), Respiratory viral infections research(30)

Publications327 total

The role of KLF4 in phagocyte activation during infectious diseases
Frontiers in Immunology·2025· 2 citedOpen Access
SARS-CoV-2 Infection of Human Lung Air-Liquid Interface Cultures Reveals Basal Cells as Relevant Targets
The Journal of Infectious Diseases·2025· 1 cited
3R centres contributions to change animal experimentation
EMBO Reports·2024· 3 citedOpen Access
Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus
European Respiratory Journal·2024· 6 citedOpen Access
Simultaneous Lung Cell and Nucleus Segmentation From Labelled Versus Unlabelled Human Lung DIC Images
2024
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
Nature Communications·2024· 18 citedOpen Access
Correction: State-of-the-art analytical methods of viral infections in human lung organoids
PLoS ONE·2023· 1 citedOpen Access
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)
Infection·2023· 3 citedOpen Access
Ex vivo infection model for Francisella using human lung tissue
Frontiers in Cellular and Infection Microbiology·2023· 11 citedOpen Access
The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment
Histochemistry and Cell Biology·2023· 10 citedOpen Access
Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
Frontiers in Medicine·2023· 7 citedOpen Access
The bat-borne influenza A virus H9N2 exhibits a set of unexpected pre-pandemic features
Research Square (Research Square)·2023Open Access
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Hepatology International·2023· 23 citedOpen Access
Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria
Infection·2023· 14 citedOpen Access
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients
European Respiratory Journal·2023Open Access
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
Figshare·2023Open Access
State-of-the-art analytical methods of viral infections in human lung organoids
PLoS ONE·2022· 5 citedOpen Access
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation
Science Translational Medicine·2022· 26 cited
Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virus
Scientific Reports·2022· 12 citedOpen Access
The Current Status and Work of Three Rs Centres and Platforms in Europe*
Alternatives to Laboratory Animals·2022· 18 cited
page 1 of 17Next →

Frequent Co-authors

Norbert Suttorp(41), Andreas C. Hocke(27), Bernd Schmeck(18), Bastian Opitz(17), Martin Witzenrath(15), Leif Erik Sander(12), Florian Kurth(11), Christian Drosten(10), Matthias Krüll(9), Victor M. Corman(8), Joachim Seybold(8), Daniel Wendisch(7), Charlotte Thibeault(7), Hortense Slevogt(7), Thorsten Wolff(6), Vincent van Laak(6), Philippe Dje N’Guessan(6), Holger Müller-Redetzky(5), Alexander Uhrig(5), Philipp Georg(5)